BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic
Open Access
- 9 May 2020
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 47 (6) , 4857-4860
Abstract
The first person-to-person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia. Hospitals have been forced to reorganized their units in response to prepare for an unforeseen healthcare emergency. In this context, our laboratory (Molecular and Genomic Diagnostics Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS) re-modulated its priorities by temporarily interrupting most of the molecular tests guaranteeing only those considered “urgent” and not postponable. In particular, this paper details changes regarding the execution of germline BRCA (gBRCA) testing in our laboratory. A substantial reduction in gBRCA testing (about 60%) compared to the first 2 months of the current year was registered, but the requests have not been reset. The requesting physicians were mainly gynaecologists and oncologists. These evidences further emphasize the new era of gBRCA testing in the management of cancer patients and confirms definitively the integration of gBRCA testing/Next Generation Sequencing (NGS) into clinical oncology. Finally, a re-organization of gBRCA testing in our Unit, mainly related to delayed and reduced arrival of tests was necessary, ensuring, however, a high-quality standard and reliability, mandatory for gBRCA testing in a clinical setting.Keywords
This publication has 18 references indexed in Scilit:
- Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesCritical Reviews in Oncology/Hematology, 2019
- A comprehensive BRCA1/2 NGS pipeline for an immediate Copy Number Variation (CNV) detection in breast and ovarian cancer molecular diagnosisClinica Chimica Acta, 2018
- Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individualsThe Breast, 2017
- Competitive PCR-High Resolution Melting Analysis (C-PCR-HRMA) for large genomic rearrangements (LGRs) detection: A new approach to assess quantitative status of BRCA1 gene in a reference laboratoryClinica Chimica Acta, 2017
- Familial pancreatic cancerSeminars in Oncology, 2016
- Familial Risk and Heritability of Cancer Among Twins in Nordic CountriesJAMA, 2016
- Clinical impact on ovarian cancer patients of massive parallel sequencing forBRCAmutation detection: the experience at Gemelli hospital and a literature reviewExpert Review of Molecular Diagnostics, 2015
- The Heritability of Prostate Cancer in the Nordic Twin Study of CancerCancer Epidemiology, Biomarkers & Prevention, 2014
- Familial pancreatic cancer—current knowledgeNature Reviews Gastroenterology & Hepatology, 2012
- GermlineBRCAMutations Denote a Clinicopathologic Subset of Prostate CancerClinical Cancer Research, 2010